Cross-suppression of EGFR ligands amphiregulin and epiregulin and de-repression of FGFR3 signalling contribute to cetuximab resistance in wild-type KRAS tumour cells
about
Genomic aberrations in the FGFR pathway: opportunities for targeted therapies in solid tumorsEpidermal growth factor is a potential biomarker for poor cetuximab response in tongue cancer cells.A novel 3D human glioblastoma cell culture system for modeling drug and radiation responses.The impact of polyphenols on chondrocyte growth and survival: a preliminary reportInhibition of fibroblast growth factor receptor 3-dependent lung adenocarcinoma with a human monoclonal antibody.FGFR3-TACC3 fusion proteins act as naturally occurring drivers of tumor resistance by functionally substituting for EGFR/ERK signaling.Personalizing colon cancer therapeutics: targeting old and new mechanisms of action.Cardiac actions of fibroblast growth factor 23.Prognostic value of amphiregulin and epiregulin mRNA expression in metastatic colorectal cancer patients.
P2860
Q26998790-89C2F400-D6D5-4E9C-8951-3577DA1FA875Q27853131-3405E422-8D97-4685-AC25-1A6F1092355AQ33777423-5C61192D-183E-4479-A978-4194FC5E8B23Q36127934-3C1188C2-E783-485E-A70C-12DE1546F454Q36967528-1D6D1200-BD2E-4338-88C6-F541AAF93C37Q37622191-CC15D4A1-65FA-4D9F-A20C-E98BDAF7079FQ38166233-A5CB34E9-870A-4BCF-B462-72A1DA9D0784Q38977291-2E6752A0-176E-42DC-B256-2F2C99D7B02BQ42317498-6F0C64B8-71A6-413E-9A41-254832CC8B25
P2860
Cross-suppression of EGFR ligands amphiregulin and epiregulin and de-repression of FGFR3 signalling contribute to cetuximab resistance in wild-type KRAS tumour cells
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Cross-suppression of EGFR liga ...... in wild-type KRAS tumour cells
@en
type
label
Cross-suppression of EGFR liga ...... in wild-type KRAS tumour cells
@en
prefLabel
Cross-suppression of EGFR liga ...... in wild-type KRAS tumour cells
@en
P2093
P2860
P356
P1476
Cross-suppression of EGFR liga ...... in wild-type KRAS tumour cells
@en
P2093
A Vazquez-Martin
B Martin-Castillo
C Oliveras-Ferraros
J A Menendez
R de Llorens
P2860
P2888
P304
P356
10.1038/BJC.2012.103
P407
P577
2012-04-01T00:00:00Z
P5875
P6179
1033904921